- Home
- CLST vs PEPG Comparison
CLST vs PEPG Comparison
Compare CLST & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- PEPG
- Stock Information
- Founded
- CLST 1922
- PEPG 2018
- Country
- CLST United States
- PEPG United States
- Employees
- CLST N/A
- PEPG N/A
- Industry
- CLST
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- CLST
- PEPG Health Care
- Exchange
- CLST Nasdaq
- PEPG Nasdaq
- Market Cap
- CLST 48.8M
- PEPG 52.4M
- IPO Year
- CLST N/A
- PEPG 2022
- Fundamental
- Price
- CLST $12.00
- PEPG $1.46
- Analyst Decision
- CLST
- PEPG Buy
- Analyst Count
- CLST 0
- PEPG 3
- Target Price
- CLST N/A
- PEPG $7.67
- AVG Volume (30 Days)
- CLST 5.1K
- PEPG 224.5K
- Earning Date
- CLST 04-24-2025
- PEPG 05-08-2025
- Dividend Yield
- CLST N/A
- PEPG N/A
- EPS Growth
- CLST N/A
- PEPG N/A
- EPS
- CLST 0.57
- PEPG N/A
- Revenue
- CLST $11,257,000.00
- PEPG N/A
- Revenue This Year
- CLST N/A
- PEPG N/A
- Revenue Next Year
- CLST N/A
- PEPG N/A
- P/E Ratio
- CLST $21.12
- PEPG N/A
- Revenue Growth
- CLST 200.91
- PEPG N/A
- 52 Week Low
- CLST $10.67
- PEPG $0.88
- 52 Week High
- CLST $12.40
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- CLST 62.86
- PEPG 48.32
- Support Level
- CLST $11.62
- PEPG $1.40
- Resistance Level
- CLST $12.00
- PEPG $1.73
- Average True Range (ATR)
- CLST 0.14
- PEPG 0.17
- MACD
- CLST 0.02
- PEPG 0.01
- Stochastic Oscillator
- CLST 50.00
- PEPG 32.50
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.